What supplements should be avoided by individuals on Dual Antiplatelet (DAPT)/Anticoagulant Therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Supplements to Avoid on Dual Antiplatelet/Anticoagulant Therapy

Patients on dual antiplatelet therapy (DAPT) or combined antiplatelet/anticoagulant therapy should avoid supplements with antiplatelet or anticoagulant properties, as these significantly increase bleeding risk beyond the already elevated baseline from their prescribed medications.

High-Risk Supplements That Must Be Avoided

Supplements with Strong Antiplatelet Effects

Hold these supplements for at least 2 weeks before any procedure and avoid entirely while on DAPT/anticoagulation:

  • Ginkgo biloba - Ginkgolide B displaces platelet-activating factor from binding sites, decreasing coagulation and interacting with warfarin, with case reports of bleeding 1
  • Ginger - Laboratory evidence shows inhibition of thromboxane synthetase with decreased platelet aggregation 1
  • Garlic (concentrated supplements) - Contains ajoene with antiplatelet properties and reinforces warfarin action 2, 3
  • Vitamin E (high doses) - Has vitamin K antagonist activity and antiplatelet effects 1, 2
  • Turmeric/Curcumin - Anti-inflammatory and antiplatelet effects with concern for increased perioperative bleeding 1
  • Bromelain - Enzymes from pineapple with anti-inflammatory and antiplatelet effects 1

Supplements with Anticoagulant Properties

These supplements potentiate anticoagulant effects and must be avoided:

  • Danshen (Salvia miltiorrhiza) - Has antithrombin III-like activity and reinforces warfarin action 2, 3
  • Ginseng - Reinforces warfarin action through heterogeneous mechanisms 3
  • Devil's Claw - Reinforces warfarin action 3
  • Horse Chestnut - May interfere with coagulation 1, 3
  • Red Clover - Reinforces warfarin action 3
  • Dong Quai - Has anticoagulant effects 2

Additional High-Risk Supplements

  • St. John's Wort - Interferes with drug metabolism and diminishes anticoagulant effect; patients taking oral anticoagulants should avoid this entirely 2, 4
  • Ganoderma Japonicum - Reinforces warfarin action 3
  • Papaw - Reinforces warfarin action 3
  • Quinine - Reinforces warfarin action 3

Moderate-Risk Supplements Requiring Caution

Supplements That May Affect Coagulation

  • Coenzyme Q10 - Has vitamin K-like activity and may affect blood clotting 2
  • Alfalfa - High vitamin K content may interfere with warfarin efficacy 2
  • Arnica - May potentiate antiplatelet drugs with in vitro antiplatelet effects 1
  • Boldo - Contains ascaridole with antiplatelet effects and may potentiate anticoagulants 1
  • Chondroitin and Glucosamine - May be held for 48 hours due to rapid metabolism, though lower risk 1

Food-Based Considerations

  • Mango (more than one fruit) - Can potentiate warfarin effects 4
  • Ginger in food quantities - Even small quantities (excluding commercial ginger-flavored beverages) can potentiate warfarin 4
  • Green leafy vegetables - High daily vitamin K content (more than 250 µg) may decrease warfarin efficacy; maintain highly constant intake if consuming 4

Supplements That Are Generally Safe

Can Be Continued

  • Fish oil/omega-3 fatty acids - Should be continued; prior concerns about bleeding risk have not been borne out in prospective studies 1
  • Green tea extract - May be continued until surgery; while it may increase bleeding risk, the catechins improve diastolic cardiac function 1
  • Cranberry juice - Consumption up to 240 mL/day (and probably more) with warfarin is safe 4
  • Grapefruit juice - Less than 240 mL daily is unlikely to interact with oral anticoagulants 4
  • German chamomile - No data suggest CNS effects that would interfere with therapy 1

Critical Clinical Considerations

Bleeding Risk Assessment

The combination of DAPT or antiplatelet/anticoagulant therapy with supplements creates additive bleeding risk that can be life-threatening 1. The European Society of Cardiology emphasizes that concomitant antiplatelet/anticoagulant use confers additive risk for bleeding 1.

Protective Measures Recommended

While on DAPT or combined therapy, implement these bleeding risk reduction strategies:

  • Proton pump inhibitor (PPI) therapy - Recommended for all patients on DAPT to reduce gastrointestinal bleeding 1, 5
  • Maintain aspirin dose at 75-100 mg daily - Higher doses increase bleeding without improving efficacy 1, 5
  • Monitor for bleeding symptoms - Any unexplained bleeding warrants immediate evaluation 1

Common Clinical Pitfalls

  • Patients often fail to disclose supplement use - Directly ask about all supplements, herbal products, and "natural" remedies at every visit 3
  • Assuming "natural" means safe - Many patients believe herbal medicines have no side effects or interactions 3
  • Overlooking food-based sources - Concentrated forms in supplements differ significantly from dietary intake 4
  • Not recognizing cumulative risk - The combination of prescribed anticoagulants/antiplatelets plus supplements creates exponentially higher bleeding risk than either alone 1

Quality and Contamination Concerns

There are neither studies on effectiveness nor controls over quality and safety of herbal preparations 3. Allergic reactions, direct toxic effects, contamination, and heavy metal toxicity have been reported as adverse events caused by herbs 3. Approximately 180 dietary supplements have potential to interact with warfarin, and more than 120 may interact with aspirin, clopidogrel, and dipyridamole 2.

Practical Algorithm for Supplement Assessment

When evaluating any supplement for a patient on DAPT/anticoagulation:

  1. Assume risk until proven safe - Given limited high-quality evidence and heterogeneity in herbal product contents 4
  2. Check for antiplatelet or anticoagulant properties - If present, recommend discontinuation 1, 2, 3
  3. If uncertain, discontinue 2 weeks before any procedure - This timeframe allows clearance of most supplements with bleeding risk 1
  4. Document all supplements - Include specific products, doses, and duration of use 3
  5. Educate patients - Explain that "natural" does not mean safe when combined with anticoagulants/antiplatelets 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Oral anticoagulants and medicinal plants. An emerging interaction].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 2000

Guideline

Dual Antiplatelet Therapy Regimen for Acute Coronary Syndrome and Coronary Stent Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.